baber/WOPTO huggingface dataset:
Patent NZ-573411-A (NZ)
Title: Cistern with two tipping buckets mounted for rotation together and rotatable in different directions for respective full and reduced flush
Inventor: ENGLAND SAM ROBERTSON
IPC: E03D1/20
Filed: 2007-08-09
Abstract: The dual flush cistern or flush tank (1) is disclosed having first (11) and second tipping buckets (12) each of which is pivotally mounted on a common axis of rotation (14). Each bucket is substantially a hollow half cylinder but the first bucket has a cover (19) typically as a half-cylinder, and the second bucket has an open top. Turning both buckets in one direction empties the second bucket but retains the water in the first bucket within the cover to create a reduced flush. However, turning both buckets in the opposite direction empties the second bucket and also empties the second bucket via an off centre exit aperture (21). The bucket preferably empty into a water director (6). A transfer aperture 22 allows water to be delivered to one bucket and overflow to the other with the inlet valve sensing the water level in the other bucket. Thus both buckets are filled via a single water inlet arrangement with an inlet (not shown) typically provided through hollow stub shaft 10. The cistern has a housing (not shown) shaped to be wall mounted to the rear of a lavatory pan upon which the user sits. The housing has front and rear, and left and right axes defined by a sitting user and the bucket axis of rotation is substantially parallel to the front and rear axis.
Patent NZ-574050-A (NZ)
Title: Edge-lift anchor for embedment into a concrete component for tilt-up lifting
Inventor: FLETCHER GEOFFREY ALAN
IPC: E04C5/12
Filed: 2007-06-27
Abstract: Disclosed is an edge-lift anchor for embedment into a concrete component for tilt-up lifting. The anchor comprises a head (2) and an anchoring portion (4). The head (2) is for releasable engagement with the lifting equipment. The anchoring portion (4) extends from the head (2) to lock the anchor into the surrounding concrete. The head (2) has an aperture (12) within a lower part, as considered in relation to the installed condition of the anchor. This aperture (12) can receive the concrete which anchors the head against shear forces acting on the head during the tilt-up phase of lifting. The head (2) is so shaped that its lower edge (12a) is formed with a downwards extension (12) containing at least a lower part of the aperture (12). The upper edge of the head (2) has a recess (16) for accommodating one or more perimeter bars (18) which may be incorporated as part of the reinforcement of the concrete component. The recess (16) is of complimentary shape to that of the downwards extension (14).
Patent NZ-577560-A (NZ)
Title: Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
Inventor: DOWNIE KEN
IPC: A61K9/22
Filed: 2008-01-16
Abstract: Disclosed is the use of i) one or more polyglycols selected from polyethylene glycols and/or polyethylene oxides and ii) one or more drug substances for the preparation of a pharmaceutical composition that is without ethanol induced dose dumping and wherein the drug substance is released by erosion of a matrix composition comprising said one or more polyethylene glycols and/or polyethylene oxides and said one or more drug substances, and wherein said matrix composition is partly coated with a polymer that is substantially insoluble, non-erodable and non-permeable to water leaving non-coated areas of the matrix exposed for release of the drug substance, wherein said polymer is selected from the group consisting of: ethylcellulose, cellulose acetate, cellulose propionate, cellulose nitrate, methylcellulose, carboxymethylcellulose and salts thereof, cellulose acetate phthalate, microcrystalline cellulose, ethylhydroxyethylcellulose, ethylmethylcellulose, hydroxyethylcellulose, hydroxyethylmethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, hydroxymethylcellulose and hydroxymethylpropylcellulose, poly(methyl)acrylates, polyamide, polyethylene, polyethylene terephthalate, polypropylenem polyurethane, polyvinyl acetate, polyvinyl chloride, silicone rubber, latex, polyhydroxybutyrate, polyhydroxyvalerate, teflon, polylactic acid or polyglycolic acid and copolymers thereof, the copolymers selected from the group consisting of ethylene vinyl acetate (EVA), styrene-butadienestyrene (SBS) and styrene-isoprene-styrene (SIS),copolymers of polylactic acid and polyglycolic acid and the co-polymer of methacrylategalactomannan.
Patent NZ-579984-A (NZ)
Title: Allocating business to a provider based on a parameter of information with a subset being communicated
Inventor: MCMILLAN BARRY
IPC: G06Q10/00
Filed: 2009-09-29
Abstract: Disclosed is a system for allocating business among a plurality of entities. The system comprises a computer network; a client terminal coupled to the computer network, the terminal communicating information about the business to the computer network; and a central processor coupled to the computer network. The processor is configured to: receive, over the network, the information about the business; process the information to determine whether the business is capable of being automatically allocated; if the business is capable of being automatically allocated, process at least one relevant parameter from the information to identify a provider to which to allocate the business; and allocate the business to the provider. Allocating the business includes communicating at least a subset of the information to the provider over the network.
Patent NZ-585306-A (NZ)
Title: 8-Anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
Inventor: PRICE STEPHEN
IPC: A61K31/437
Filed: 2008-12-18
Abstract: Disclosed are compounds of formula (I') and methods of their preparation. Specific examples of compounds of formula (I') include 8-(4-cyclopropyl-2-fluoro-phenylamino)-imidazo[1,5-a]pyridine-7-carboxylic acid (2-hydroxy-ethoxy)-amide, 8-(4-cyclopropyl-2-fluoro-phenylamino)-imidazo[1,5-a]pyridine-7-carboxylic acid ((S)-2-hydroxy-propoxy)-amide, 8-(4-bromo-2-fluoro-phenylamino)-imidazo[1,5-a]pridine-7-carboxylic acid (2-hydroxy-ethoxy)-amide, and 8-(4-Bromo-2-chloro-phenylamino)-imidazo[ 1,5-a]pyridine-7-carboxylic acid (2-hydroxy-ethoxy)-amide. Also disclosed is the use of compounds of formula (I') for treating an inflammatory disease, inhibiting abnormal cell growth or treating a hyperproliferative disorder
Patent NZ-587039-A (NZ)
Title: 6-aryl-imidazo[1, 2-a]pyrazine derivatives, method of making, and method of use thereof
Inventor: MITCHELL SCOTT A
IPC: A61K31/4985
Filed: 2009-02-12
Abstract: Disclosed are imidazopyrazine compounds of formula (I), salts thereof, and methods for their preparation. Specific examples of compounds of Formula (I) include: 4-{ 8-[(3,4-dimethoxyphenyl)amino]imidazo[1,2-a]pyrazin-6-yll-N-[2-(dimethylamino)ethyl]benzamide; 5-{ 8-[(3,4-dimethoxyphenyl)amino]imidazo[1,2-a]pyrazin-6-yl} pyridine-3-carboxamide; 4-({ 3-[8-(1H-Indazol-6-ylamino)-imidazo[1,2-a]pyrazin-6-yl]benzene} amido)benzoic acid. Compounds of Formula (I) are inhibitors of spleen tyrosine kinase (Syk). The compounds are useful for treating a disease responsive to the inhibition of Syk activity selected from the group comprising allergic disorders, autoimmune diseases and inflammatory diseases such as: SLE, rheumatoid arthritis, multiple vasculitides, idiopathic thrombocytopenic purpura (ITP), myasthenia gravis, allergic rhinitis, chronic obstructive pulmonary disease (COPD), adult respiratory distress syndrome (ARDs) and asthma.
Patent NZ-588671-A (NZ)
Title: Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
Inventor: TAN PHILIP
IPC: A61K31/4184
Filed: 2009-04-11
Abstract: Disclosed is a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B cell related autoimmune, inflammatory, or hyperproliferative diseases.
Patent NZ-591894-A (NZ)
Title: Apparatus for producing hydrogen-dissolved drinking water and process for producing the dissolved drinking water
Inventor: SUMITA OSAO
IPC: C25B9/23
Filed: 2009-10-16
Abstract: Disclosed is a hydrogen-dissolved drinking water production apparatus to reduce the effect of active oxygen ions. The apparatus comprises an electrolytic cell through which water can pass for producing drinking water having a pH in a range of 5.8 to 8.5 and a dissolved hydrogen concentration of 0.1 ppm or more by supplying high-purity water having a conductivity of 50 j.tS/cm or less. The electrolytic cell comprises a vertical anode chamber having a water-permeable plate-like anode electrode and a vertical cathode chamber having a plate-like cathode electrode. The anode chamber and the cathode chamber are separated by a diaphragm formed from a fluorine-based cation exchange membrane. The water-permeable plate-like anode electrode is closely adhered to the diaphragm formed from the fluorine-based cation exchange membrane, and an ion-exchange resin is filled in a space between the diaphragm and the cathode electrode.
Patent NZ-592105-A (NZ)
Title: Enhanced device for the artificial insemination of sheep, goats, deer and/or domestic and wild animals
Inventor: HIDALGO-MENDOZA MARCO ANTONIO
IPC: A61D19/02
Filed: 2009-10-05
Abstract: 592105 An artificial-insemination device formed by joining a small straw or tube filled with semen to one end of a pipette (10), the other end of which is attached to a syringe (16) is disclosed. An attachable point (18) is connected to the other end of the semen-filled tube. The semen-filled tube is connected by the formation of fitting apertures in the pipette and the attachable point, such that semen-filled tubes of varying diameters may be forced tightly within the fitting apertures. The pipette-tube-point unit is inserted into the vagina of the animal using a speculum until the point with one or more bends, one or more apertures and a spherical seal, enters the cervix, and a seal is formed between the point and the cervix. The syringe, which contains the diluent fluid, is pressed to force the semen and the diluent fluid out through at least one ejection outlet in the point towards the animal's uterus. Optimum quantities of semen and diluent fluid may be provided for different animals.
Patent NZ-592346-A (NZ)
Title: Temporary Shaft Support System For Shaft Within Enclosure By Holding and Lifting Shaft From Above And Supporting From Enclosure
Inventor: ISENBERG TIMOTHY J
IPC: F16C41/00
Filed: 2011-04-19
Abstract: A temporary shaft support system (100) is provided that can be used with an enclosure (7) such as food processing equipment. The system may include a holder (110) for engaging a shaft (45) to be supported, and a lift (150) that is supported from the food processing equipment at a position that is higher than the shaft to allow the shaft to be suspended and supported without occupying floor space of the food processing equipment. The lift may be supported by a top wall (10) of the food processing equipment or may be supported by a drive mount (52) that attaches a shaft-rotating drive to the food processing equipment.
Patent NZ-593634-A (NZ)
Title: Fungicidal compositions of cyprodinil and flutianil ((2Z)-2-(2-fluoro-5-(trifluoromethyl)phenylthio)-2-(3-(2-methoxyphenyl)thiazolidin-2-ylidene)acetonitrile)
Inventor: FORSTER BIRGIT
IPC: A01N43/78
Filed: 2006-09-27
Abstract: Disclosed is a composition which comprises in addition to customary inert formulation adjuvants, as active ingredient a mixture of Cyprodinil and a synergistically effective amount of Flutianil ((2Z)-2-(2-fluoro-5-(trifluoromethyl)phenylthio)-2-(3-(2-methoxyphenyl)thiazolidin-2-ylidene)acetonitrile); for control of diseases on useful plants or on propagation material thereof, said diseases being caused by phytopathogens. Further disclosed is a method of controlling diseases on useful plants or on propagation material thereof, which comprises applying to the useful plants, the locus thereof or propagation material thereof a composition as defined above.
Patent NZ-594605-A (NZ)
Title: Pharmaceutical compositions comprising anti miRNA antisense oligonucleotides
Inventor: ELMEN JOACIM
IPC: C12N15/11
Filed: 2007-03-30
Abstract: Disclosed is a single-stranded oligonucleotide 8 to 24 nucleotides in length capable of reducing an effective amount of a miRNA in vitro or in a non-human cell or non-human organism, wherein said single stranded oligonucleotide comprises: (i) a sequence that is complementary to a sequence of said miRNA; (ii) a sequence comprising not more than 4 consecutive 2'-deoxyribose nucleoside (DNA) units; (iii) a sequence comprising more than 4 consecutive Locked Nucleic Acid (LNA) units; (iv) at least 30% of constituent nucleotides as LNA units; and (v) at least one internucleoside linkage group comprising a phosphorothioate, subject to the proviso that the single-stranded oligonucleotide does not comprise a core DNA sequence of 3'-ctcaca-5' from positions two to seven or from positions three to eight thereof counting from the 3' end of said oligonucleotide.
Patent NZ-595918-A (NZ)
Title: Genetic markers for risk management of atrial fibrillation and stroke
Inventor: HOLM HILMA
IPC: C12Q1/68
Filed: 2010-03-30
Abstract: 595918 TREATMENT OF INFLAMMATORY DISEASES USING PLACENTAL STEM CELLS Provided is a method of determining a susceptibility to a condition selected from the group consisting of: a cardiac arrhythmia selected from Atrial Fibrillation and Atrial Flutter, and Stroke, in a human individual, the method comprising: obtaining nucleic acid sequence data about a human individual identifying at least one allele of at least one polymorphic marker, wherein different alleles of the at least one polymorphic marker are associated with different susceptibilities to the condition in humans, and determining a susceptibility to the condition from the sequence data, wherein the at least one polymorphic marker is selected from the group consisting of rs7193343, and markers in linkage disequilibrium therewith.
Patent NZ-597215-A (NZ)
Title: Compositions and methods for producing a composition
Inventor: LEISTER KIRK J
IPC: A61K38/17
Filed: 2006-12-19
Abstract: Disclosed is a composition comprising cytotoxic T lymphocyte antigen 4 immunoglobulin (CTLA4-Ig) molecules that is characterized by: (a) an average molar ratio of N-acetyl neuraminic acid (NAN A) to CTLA4-Ig molecules of from 8.0 to 11.9, and (b) less than or equal to 2.0 area percent CTLA4-Ig high molecular weight species as determined by size exclusion chromatography and spectrophotometric detection.
Patent NZ-599729-A (NZ)
Title: Stevia-containing tabletop sweeteners and methods of producing same
Inventor: CATANI STEVEN J
IPC: A23L33/20
Filed: 2008-06-26
Abstract: NZ 599729 Disclosed is a reduced calorie sweetening composition consisting of from about 2 wt% to about 4 wt% stevia extract and about 92 wt% to about 98 wt% simple sugar, wherein the stevia extract comprises a rebaudioside A level of from about 80 wt% to about 99 wt% relative to all steviol glycosides, wherein the simple sugar is selected from the group consisting of sucrose, fructose and glucose, and wherein the reduced calorie sweetening composition is packaged in sachets, packets, dissolvable sweetening strips, sprays, mists, drops, cubes, tablets or bulk forms.
Patent NZ-619235-A (NZ)
Title: L-ornithine phenyl acetate and methods of making thereof
Inventor: BEHLING JIM
IPC: C07C229/26
Filed: 2010-04-01
Abstract: Provided are processes for preparing crystalline L-ornithine phenyl acetate salts. One method of preparation involves intermixing an L-ornithine salt, a benzoate salt and a solvent to form an intermediate solution; intermixing phenyl acetate with the solution; and isolating a composition comprising at least 70% crystalline L-ornithine phenyl acetate by weight. A second method involves increasing the pH value of a solution comprising an L-ornithine salt at least until an intermediate salt precipitates, wherein said intermediate salt is not an L-ornithine salt; isolating the intermediate salt from said solution; intermixing phenyl acetic acid with said solution; and isolating an L-ornithine phenyl acetate salt from said solution. A third method involves intermixing an L-ornithine salt, silver phenyl acetate and a solvent to form a solution, wherein the L-ornithine salt is a halide salt. Further provided are crystalline L-ornithine phenyl acetate salts which may, in some embodiments, be of Form I, II, III or V, or mixtures thereof. The crystalline forms may be formulated for treating subjects with liver disorders, such as hepatic encephalopathy. Accordingly, some embodiments include formulations and methods of administering L-ornithine phenyl acetate.
Patent NZ-709742-A (NZ)
Title: Method for producing pest controlling agent
Inventor: KITSUDA SHIGEKI
IPC: C07D417/06
Filed: 2012-08-24
Abstract: Disclosed is a method for producing a 2-aminopyridine compound of formula (I) by acylating a compound represented by Formula (A) by using an acylation agent, and further alkylating a 1-position nitrogen atom of the compound represented by Formula (B) in the presence of a base. The compound is useful as a pest controlling agent.
Patent NZ-717593-A (NZ)
Title: Nanobubble-containing liquid solutions
Inventor: BAUER WALTER
IPC: B01F3/04
Filed: 2014-10-03
Abstract: Existing production of nanobubbles produce nanobubbles from a microbubble base fluid, this requires the need to utilize external gas/air to create a greater abundance of nanobubbles. This problem is overcome in the present invention which comprises a nanobubble generator, a nanobubble-containing liquid solution comprising a substantially high concentration of nanobubbles, a system and methods of producing the nanobubble-containing liquid solution. The nanobubble generator includes an inflow portion for receiving a source liquid solution, a series of at least two sequential cavitation zones and shear planes to treat the source liquid solution and producing nano-bubble containing liquid solution, and an outflow portion for releasing the nanobubble-containing liquid solution. The share planes having at least ten equally sized discs in a row and having scallop-shaped shear surfaces.
Patent NZ-724336-A (NZ)
Title: Regenerative hydraulic brake for a stuffer unit in an agricultural baler.
Inventor: VERHAEGHE DIDIER
IPC: A01F15/10
Filed: 2015-07-07
Abstract: An agricultural baler with a stuffer unit that is movable through a stuffer cycle for transferring crop material in charges into the main bale chamber may include a passive disc braking system on the stuffer shaft in order to brake the stuffer unit. The stuffer shaft is always braked during the entire stuffer cycle, not just the last phase of the cycle. Therefore, the stuffer unit must be driven with enough force to not only drive the stuffer unit itself, but also with enough force to overcome the braking force of the passive brake, this results in additional power consumption and generation of heat. Disclosed is an agricultural baler including; a hydraulic brake associated with and configured for acting as a brake on the stuffer unit during a portion of the stuffer cycle and configured for delivering power to the stuffer unit during another portion of the stuffer cycle.
Patent NZ-730919-A (NZ)
Title: New 2’ and/or 5’ amino-acid ester phosphoramidate 3’-deoxy adenosine derivatives as anti-cancer compounds
Inventor: GRIFFITH HUGH
IPC: A61K31/7076
Filed: 2015-11-27
Abstract: The present invention relates to chemical compounds, the compounds for use in a method of treatment, particularly in a method of prophylaxis or treatment for cancer, a process for preparation of the compounds and pharmaceutical compositions comprising the compounds. The compounds may, in particular, be useful in the treatment of leukaemia, lymphoma and/or solid tumours inhomo sapiens. The compounds are derivatives of cordycepin (3’-deoxyadenosine) having a 2’ and/or 5’- amino-acid ester phosphoramidate moeity.
Patent NZ-732301-A (NZ)
Title: Peptide compound, preparation method therefor, and application thereof
Inventor: ZHENG XIAOHUI
IPC: C07K5/078
Filed: 2015-11-27
Abstract: Provided are a tripeptide compound, a preparation method therefor, and an application thereof. The structure of the related compound is represented by formula (I). The provided compound has angiotensin converting enzyme inhibiting bioactivity, and the compound and a pharmaceutical composition thereof play a role in preventing and treating hypertension and other cardiocerebral vascular system diseases.
Patent NZ-735713-A (NZ)
Title: A method of producing sugar from paper
Inventor: MASTERMAN THOMAS
IPC: C13K1/02
Filed: 2012-02-14
Abstract: Disclosed a saccharifying process for converting a paper feedstock into sugars, and their subsequent fermentation, wherein the feedstock is a high density paper having a basis weight of at least 35 lb (i.e. the weight in pounds (lb) for a ream (500 sheets) of 25” X 38” sheets) (i.e. greater than about 50 gsm) with high ash / calcium carbonate content. In particular there is provided a method of producing a sugar comprising providing a paper having a basis weight of at least 35 lb (15.9 kg) and an ash content of at least 8 wt.%. and combining the paper with a saccharifying agent (e.g. (cellulases, ligninases, cellulolytic enzymes including endoglucanases etc. etc.).
Patent NZ-739892-A (NZ)
Title: Methods and formulations for reducing bovine emissions
Inventor: HERR CORY T
IPC: A23K10/00
Filed: 2016-10-03
Abstract: The present disclosure provides methods and formulations for reducing ammonia and carbon dioxide emissions from a bovine using lubabegron, or a physiologically acceptable salt thereof. The present disclosure also provides bovine feed additives and bovine feed compositions.
Patent NZ-769427-A (NZ)
Title: Immunotherapy against several tumors including gastrointestinal and gastric cancer
Inventor: WEINSCHENK TONI
IPC: G01N33/50
Filed: 2011-03-15
Abstract: Disclosed is a peptide consisting of the sequence according to SEQ ID No. 6 (VWSDVTPLTF) inducing T cells cross-reacting with said peptide.
Patent NZ-771345-A (NZ)
Title: Test strip for detecting pendimethalin
Inventor: KUAN FANG
IPC: G01N33/577
Filed: 2020-12-18
Abstract: The present disclosure provides a test strip for detecting pendimethalin, and particularly relates to the field of pendimethalin detection. A sample pad is sequentially provided with a first absorbent layer, an antibacterial layer and a second absorbent layer from top to bottom, and edges of the first absorbent layer and the second absorbent layer are processed by hot-melt edge sealing; a conjugate pad is sequentially provided with a first airlaid paper layer, an absorbent layer and a second airlaid paper layer from top to bottom, and both sides of the conjugate pad are edge-wrapped; an absorbent pad is composed of upper airlaid paper, lower airlaid paper and super absorbent polymer (SAP) absorption units; the SAP absorption units are disposed between the upper and lower airlaid paper, and edges of the upper and lower airlaid paper are processed by hot-melt edge sealing. The present disclosure is sensitive in detection and can improve detection efficiency.